Rapid communication - Monosomy for the X-chromosome is associated with an atherogenic lipid profile

被引:66
作者
Van, Phillip L. [1 ]
Bakalov, Vladimir K. [1 ]
Bondy, Carolyn A. [1 ]
机构
[1] NICHHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1210/jc.2006-0503
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context and Objective: Men typically have a more atherogenic lipid profile than women characterized by higher low-density lipoprotein (LDL) cholesterol and triglyceride levels and reduced lipid particle size, contributing to a greater risk for coronary disease. To determine whether X-chromosomal gene dosage affects lipid metabolism independent of sex steroid effects, we compared lipid profiles in age- and body mass-matched young women with ovarian failure, differing only in X-chromosome dosage. Design, Setting, and Patients: Women with premature ovarian failure associated with monosomy X or Turner syndrome (TS, n = 118) were compared with women with 46, XX premature ovarian failure (n = 51) in an in-patient clinical research center unit at the National Institutes of Health. These women were normally on estrogen replacement treatment but discontinued the estrogen 2 wk before study. Major Outcomes: Fasting lipid levels and nuclear magnetic resonance lipid particle profiles in the two study groups were the major outcomes. Results: Average age and body mass were similar in the two groups of women, but LDL cholesterol (P = 0.001) and triglyceride levels (P = 0.0005) were higher in the TS group. Also among women with TS, average LDL particle size was reduced (P < 0.0001) and LDL particle concentration increased, with a 2-fold increase in the smallest particle categories (P < 0.0001). Whereas total high-density lipoprotein cholesterol levels were similar, high-density lipoprotein particle size was significantly smaller in women with TS, compared with women with premature ovarian failure (P < 0.0001). Conclusions: Women with 45, X with ovarian failure exhibit a distinctly more atherogenic lipid profile than 46, XX women with ovarian failure, suggesting that the second X-chromosome contributes to a more salutary lipid profile in normal women, independent of sex steroid effects.
引用
收藏
页码:2867 / 2870
页数:4
相关论文
共 23 条
[1]  
ASTZALOS BF, 2003, AM J CARDIOL, V91, P12
[2]   Impaired insulin secretion in the Turner metabolic syndrome [J].
Bakalov, VK ;
Cooley, MM ;
Quon, MJ ;
Luo, ML ;
Yanovski, JA ;
Nelson, LM ;
Sullivan, G ;
Bondy, CA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3516-3520
[3]   Unique lipoprotein phenotype and genotype associated with exceptional longevity [J].
Barzilai, N ;
Atzmon, G ;
Schechter, C ;
Schaefer, EJ ;
Cupples, AL ;
Lipton, R ;
Cheng, S ;
Shuldiner, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15) :2030-2040
[4]   A stain upon the silence: genes escaping X inactivation [J].
Brown, CJ ;
Greally, JM .
TRENDS IN GENETICS, 2003, 19 (08) :432-438
[5]   X-inactivation profile reveals extensive variability in X-linked gene expression in females [J].
Carrel, L ;
Willard, HF .
NATURE, 2005, 434 (7031) :400-404
[6]   Lipid profiles in women with 45,X vs 46,XX primary ovarian failure [J].
Cooley, M ;
Bakalov, V ;
Bondy, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (16) :2127-2128
[7]   Correlations between lipid levels and age, gender, glycemia, obesity, diabetes, and smoking [J].
Devroey, D ;
De Swaef, N ;
Coigniez, P ;
Vandevoorde, J ;
Kartounian, J ;
Betz, W .
ENDOCRINE RESEARCH, 2004, 30 (01) :83-93
[8]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[9]   Hormone replacement therapy and cardiovascular disease: does route of administration and formulation matter? [J].
Foster, W ;
Lip, GYH .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (06) :836-840
[10]   Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: The Framingham study [J].
Freedman, DS ;
Otvos, JD ;
Jeyarajah, EJ ;
Shalaurova, I ;
Cupples, LA ;
Parise, H ;
D'Agostino, RB ;
Wilson, PWF ;
Schaefer, EJ .
CLINICAL CHEMISTRY, 2004, 50 (07) :1189-1200